Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unit
Supportive Care in Cancer · 2026-07 · 34 (7)
DOI: 10.1007/s00520-026-10955-w ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Supportive Care in Cancer, online erschienen am 03.07.2026. Verfasst von Kimberly E Alexander und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Healthcare Transformation, School of Nursing, Queensland University of Technology, Brisbane, Australia. k.alexander@qut.edu.au. Hauptthemen laut MEDLINE: Quality of Life, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Queensland University of Technology.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
Individuals undergoing chemotherapy experience a range of symptoms that can significantly impact their quality of life and treatment outcomes; the prevalence and severity of which can change across their treatment journey. This study aimed to identify and describe the longitudinal symptom experience during the first four months of chemotherapy administration across a range of cancer diagnoses.
Methods
A prospective longitudinal cohort study was conducted at a cancer centre in Queensland, Australia. Monthly surveys assessed symptoms, distress, and quality of life across 4 months of chemotherapy.
Results
A total of 252 participants completed baseline surveys (mean age 61 ± 12.3 years; 65% female; 40% breast cancer). Participants reported a mean of 22.5 ± 9.0 symptoms at baseline, with a statistically significant reduction in symptoms throughout the study period 21.9 ± 9.2 symptoms ( p = 0.002). Fatigue (93%), insomnia (80%), and pain (72%) were most common at baseline and remained highly prevalent throughout the time period. Severe fatigue (25%), pain (15%), and constipation (15%) reduced over time, while peripheral neuropathy and decreased sexual interest increased.
Conclusion
This study has produced insights into the high number of symptoms experienced during the initial four months of chemotherapy. Given the impact of symptoms on treatment outcomes, there is a critical need for the development of appropriate assessment tools capable of capturing this broad range of patient symptom experiences. Implications for Cancer Survivors Understanding symptom patterns over time can support early identification of high-risk patients, guide personalised supportive care strategies and optimise treatment tolerance and quality of life during and beyond chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Healthcare Transformation, School of Nursing, Queensland University of Technology, Brisbane, Australia. k.alexander@qut.edu.au.
- Cancer and Palliative Care Outcomes Centre, Queensland University of Technology, Brisbane, Australia. k.alexander@qut.edu.au.
- Cancer Care Services, Metro North Health, Herston, Queensland, Australia. k.alexander@qut.edu.au.
- School of Nursing, Queensland University of Technology, Brisbane, Australia. k.alexander@qut.edu.au.
- Royal Brisbane and Women's Hospital, Brisbane, Australia. k.alexander@qut.edu.au.
- The University of Queensland, Brisbane, Queensland, Australia.
Förderung
- Queensland University of Technology
Zitieren
APA
Alexander, K. E., Ogle, T., Scanlon, B., Farley, M. J., Bradford, N., Pitt, E., Hoberg, H., Herron, E., Doyle, L., Abraham, R., Bentley, M., Inglis, P. L., Colosimo, M., Lane, S., & Yates, P. M. (2026). Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unit. Supportive Care in Cancer, 34(7). https://doi.org/10.1007/s00520-026-10955-w
Vancouver
Alexander KE, Ogle T, Scanlon B, Farley MJ, Bradford N, Pitt E, et al. Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unit. Supportive Care in Cancer. 2026;34(7). doi:10.1007/s00520-026-10955-w
BibTeX
@article{Alexander2026,
author = {Alexander, Kimberly E and Ogle, Theodora and Scanlon, Brighid and Farley, Morgan J and Bradford, Natalie and Pitt, Erin and Hoberg, Hana and Herron, Elizabeth and Doyle, LeeAnne and Abraham, Rick and Bentley, Mark and Inglis, Po-Ling and Colosimo, Maree and Lane, Steven and Yates, Patsy M},
title = {Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unit},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {7},
doi = {10.1007/s00520-026-10955-w}
}
EUVIMED